IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models

Rheumatology International

Volumn 33, Issue 3, 2013, Pages 671-679

  Park, Young Eun ^a   Kim, Geun Tae ^a   Lee, Seung Geun ^b   Park, Seong Hu ^a   Baek, Seung Hoon ^a   Kim, Sung Il ^a   Kim, Ju In ^a   Jin, Hua Shu ^c  

^a Kosin University College of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Collagen induced arthritis; Interleukin 32; Natural killer cell

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 32; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; BONE DESTRUCTION; DISEASE SEVERITY; LYMPHOCYTE MIGRATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED DBA; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 84879691459     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2385-5     Document Type: Article

References (40)

1. Firestein GS (2003) Evolving concept of rheumatoid arthritis. Nature 423:356-361
2. Senolt L, Vencovsky J, Pavelka K, Ospelt C, Gay S (2009) Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 9(2):102-107
3. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA (2005) Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22:131-142
4. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB (2006) IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 103:3298-3303
5. Conti P, Youinou P, Theoharides TC (2007) Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmun Rev 6(3):131-137
6. Dinarello CA, Kim SH (2006) IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 65(Suppl 3):iii61-iii64
7. Flodstrom-Tullberg M, Bryceson YT, Shi FD, Hoglund P, Liunggren HG (2009) Natural killer cells in human autoimmunity. Curr Opin Immunol 21(6):634-640
8. Yabuhara A, Yang FC, Nakazawa T, Iwasaki Y, Mori T, Koike K, Kawai H, Komiyama A (1996) A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol 23:171-177
9. Cameron AL, Kirby B, Griffiths CE (2003) Circulating natural killer cells in psoriasis. Br J Dermatol 149:160-164
10. O'Gorman M, Smith R, Garrison A, Shamiyeh E, Pachman L (2002) Lymphocyte subsets in peripheral blood from newly diagnosed, untreated patients with juvenile dermatomyositis (JDM) are associated with disease activity scores (DAS). Arthr Rheum 46(suppl 9):S490
11. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A (2003) Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142:292-296
12. Shibatomi K, Ida H, Yamasaki S, Nakashima T, Origuchi T, Kawakami A, Migita K, Kawabe Y, Tsujihata M, Anderson P, Eguchi K (2001) A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Arthr Rheum 44(4):884-892
13. Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, Wu CY, Zheng BJ, Lu L (2008) Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthr Rheum 58(9):2700-2711
14. Shoda H, Fujio K, Yamamoto K (2007) Rheumatoid arthritis and interleukin-32. Cell Mol Life Sci 64:2671-2679
15. Kim YG, Lee CK, Oh JS, Kim SH, Kim KA, Yoo B (2010) Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. Arthr Rheum 62(2):515-523
16. Mabilleau G, Sabokbar A (2009) Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS ONE 4(1):e4173
17. Harris ED (1990) Rheumatoid arthritis: pathophysiology and implications for treatment. N Engl J Med 322:1277-1289
18. Davis LS, Schulze-Koops H, Lipsky PE (1999) Human CD4+ T cell differentiation and effector function: implications for autoimmunity. Immunol Res 19(1):25-34
19. Kotzin BL, Kappler J (1998) Targeting the T cell receptor in rheumatoid arthritis. Arthr Rheum 41:1906-1910
20. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787-793
21. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146
22. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310-1316
23. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345-1352
24. Kohno K, Kurimoto M (1998) Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clin Immunol Immunopathol 86(1):11-15
25. Udagewa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT (1997) Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185(6):1005-1012
26. Olee T, Hashimoto S, Quach J, Lotz M (1999) IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 162(2):1096-1100
27. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K (1998) Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 10(3):258-264
28. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S (1998) Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8(3):383-390
29. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, Mclnners IB (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104(10):1393-1401
30. Yokoyama WM (1998) Natural killer cell receptors. Curr Opin Immunol 10:298-305
31. Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633-640
32. Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438
33. Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272:50-53
34. Kos FJ (1998) Regulation of adaptive immunity by natural killer cells. Immunol Res 17:303-312
35. Su HC, Nguyen KB, Salazar-Mather TP, Ruzek MC, Dalod MY, Biron CA (2001) NK cell functions restrain T cell responses during viral infections. Eur J Immunol 31:3048-3055
36. Zitvogel L (2002) Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 195:F9-F14
37. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186:1677-1687
38. Nilsson N, Bremell T, Tarkowski A, Carlsten H (1999) Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis. Clin Exp Immunol 117:63-69
39. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610-621
40. Szekanecz Z, Kim J, Koch AE (2003) Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 15(1):15-21